晚期子宫脱垂不同腹腔镜骶骨固定术式的比较:一项回顾性分析
单中心回顾性队列研究纳入483例晚期子宫脱垂患者,比较腹腔镜骶骨子宫固定术(LSH)、腹腔镜次全子宫切除联合骶骨宫颈固定术(LSCH+LSC)与全腹腔镜子宫切除联合骶骨阴道固定术(TLH+LSC)的长期结局。中位随访32个月,三组解剖治愈率无显著差异(p=.273),但TLH+LSC组严重术后并发症(含网片暴露)显著更高(p<.001)。
要点
- LSH组失血量、术后住院天数和导尿天数均最少(均p<.001)。
- 三组解剖治愈率无显著差异(p=.273),脱垂复发与功能改善亦无显著差异。
- TLH+LSC组严重术后并发症(含网片暴露)显著高于其他两组(p<.001)。
核心结论
- LSH是无子宫保留禁忌的子宫脱垂女性的合适选择。
- 对于良性子宫病变且宫颈正常的患者,LSCH+LSC是更安全的方法,其解剖结果与生活质量评分与TLH+LSC相似。
- 对于子宫和宫颈均有病变的患者,应选择TLH+LSC。
研究设计与样本
- 单中心回顾性队列研究,在一所三级大学医院开展。
- 共纳入483例晚期子宫脱垂患者,其中277例行LSH,95例行LSCH+LSC,111例行TLH+LSC。
- 数据提取自医疗记录和随访记录,时间范围为2012年4月至2020年12月。
主要发现
- LSH组失血量、术后住院天数和导尿天数均最少(均p<.001)。
- 中位随访32个月(范围13-117个月)期间,三组盆腔器官脱垂定量测量均显示显著解剖矫正(p<.001)。
- 三组解剖治愈率无显著差异(p=.273),脱垂复发(p=.171)和功能改善亦无显著差异。
- 术中损伤(p=.098)和术后总并发症(p=.218)无显著差异,但TLH+LSC组严重术后并发症发生率显著高于其他两组(p<.001),包括网片暴露(p=.004)。
关键数值与推荐
- 解剖治愈率三组间无显著差异(p=.273)。
- 脱垂复发三组间无显著差异(p=.171)。
- 严重术后并发症发生率TLH+LSC组显著高于其他两组(p<.001),网片暴露TLH+LSC组显著高于其他两组(p=.004)。
临床怎么用
- 作者认为,LSH是无子宫保留禁忌的子宫脱垂女性的合适选择。
- 作者认为,对于良性子宫病变且宫颈正常的患者,LSCH+LSC是更安全的方法。
- 作者认为,对于子宫和宫颈均有病变的患者,应选择TLH+LSC。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To compare the long-term outcomes and complications of 3 different variants of laparoscopic sacropexy. DESIGN: Single-center retrospective cohort study. SETTING: A tertiary university hospital. PATIENTS: A total of 483 patients with advanced uterine prolapse who underwent laparoscopic sacrohysteropexy (LSH), laparoscopic supracervical hysterectomy with concomitant laparoscopic sacrocervicopexy (LSCH + LSC), or total laparoscopic hysterectomy with concomitant laparoscopic sacrocolpopexy (TLH + LSC). INTERVENTIONS: Demographic data, Pelvic Organ Prolapse Quantification scores, questionnaire results, surgical conditions, postoperative outcomes, and complications were all extracted from medical and follow-up records. MEASUREMENTS AND MAIN RESULTS: Between April 2012 and December 2020, 277 women underwent LSH, 95 women underwent LSCH + LSC, and 111 women underwent TLH + LSC. LSH procedures were associated with statistically significantly least blood loss and least postoperative hospital days and catheterization days (all p <.001). During the median follow-up of 32 months (13-117 months), analysis of the data revealed notable anatomic correction in all groups regarding Pelvic Organ Prolapse Quantification measurements (p <.001), and the anatomic cure rate showed no significant difference among these 3 groups (p = .273). No statistically significant differences were detected for prolapse recurrence (p = .171) and functional improvements among these groups. Neither intraoperative injuries (p = .098) nor total postoperative complications (p = .218) differed considerably, whereas the rate of severe postoperative complications (p <.001) including mesh exposure (p = .004) was significantly higher in the TLH + LSC group than that in the other groups. CONCLUSIONS: LSH is the appropriate choice for women with uterine prolapse without contraindications for uterine preservation. For patients with benign uterine lesions and a normal cervix, LSCH + LSC is a safer approach that provides similar anatomic results and improved quality of life scores that are similar to those of TLH + LSC. For patients with lesions in the uterus and cervix, TLH + LSC should be selected.
引用
- Yan L, Lu S, Zhao C, et al. Comparison of Different Laparoscopic Sacropexy Procedures for Advanced Uterine Prolapse: A Retrospective Analysis. J Minim Invasive Gynecol. 2022. PMID: 36563872. doi:10.1016/j.jmig.2022.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。